IL17A and histiocytic sarcoma: Proteome studies provide evidence that the innate immunity system and both IL-1 and IL-17 signaling pathways are activated in HS lesions and circulating neutrophils [27,40,45,71,72,73], findings that have been confirmed in our systematic review.